Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_assertion type Assertion NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_head.
- NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_assertion description "[The induction of EMT did not enhance tumour-initiating capacity but, instead, conferred a CD44(+)/CD24(-/low) phenotype as well as cell proliferation, migration, and resistance to doxorubicin and radiation on breast cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_provenance.
- NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_assertion evidence source_evidence_literature NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_provenance.
- NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_assertion SIO_000772 24755887 NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_provenance.
- NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_assertion wasDerivedFrom befree-20150227 NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_provenance.
- NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_assertion wasGeneratedBy ECO_0000203 NP296308.RAfAxrzKvhu3bJK5UOIiJpx-tBMtgR4h61QaehsCr_SME130_provenance.